FDA Inspection 869289 — Sharp Global Limited
The FDA completed an inspection of Sharp Global Limited on March 10, 2014 in New Delhi. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 10, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- New Delhi (India)